s6y
Company name or ticker
Search
Allen Andrew R
3
Adaptimmune Therapeutics PLC: Initial statement of beneficial ownership of securities
Filed
Thursday, June 1, 2023
Period
Jun 1, 2023
Accession number
0001104659-23-067105
Documents
OWNERSHIP DOCUMENT
3
On sec.gov
Filing index
All files
Complete submission text
SGML header